Crescent Capital Bdc, Inc. · NASDAQ:CCAP
Crescent Capital Bdc — Q2 2026 Earnings Presentation
19 slides from Crescent Capital Bdc's earnings presentation, Aug 11, 2026
Slide 1: Quarterly Earnings Presentation
Crescent Capital BDC, Inc. Quarterly Earnings Presentation June 30, 2026
Slide 2: Disclaimer and Forward-Looking Statement
Disclaimer and Forward-Looking Statement This presentation (the “Presentation”) has been prepared by Crescent Capital BDC, This Presentation may contain forward-looking statements that involve substantial Inc. (together with its consolidated subsidiaries, “CCAP,” “Crescent BDC” or the risks and unce
Slide 3: Crescent Capital BDC, Inc. (CCAP)
Crescent Capital BDC, Inc. (CCAP) Specialty finance company focused on investing in the debt of private U.S. middle-market companies $1,571 Ticker CCAP Exchange NASDAQ Total Net Assets $656 million Net Asset Value per Share $17.82 Total Assets $1.6 billion Total Portfolio Investments ($mm) Q2’15 (In
Slide 4: Summary of Financial Results
Current or prospective client name Summary of Financial Results 4
Slide 5: Second Quarter 2026 Highlights
Second Quarter 2026 Highlights • Net investment income (NII) per share for the quarter ended June 30, 2026 was $0.36, as compared to $0.42 for the prior quarter Second Quarter Performance • Net realized and unrealized losses on investments per share for the quarter ended June 30, 2026 of ($0.45). Th
Slide 6: Enhancements to Fee Structure to Improve Shareholder Alignment
Enhancements to Fee Structure to Improve Shareholder Alignment • CCAP permanently reduced its base management fee to 1.00% (from 1.25%) and its incentive fee to 15.0% (from 17.5%) – Immediate income accretion to shareholders – Effective as of April 1, 2026 • These reductions improve dividend coverag
Slide 7: Financial Highlights
Financial Highlights $ in millions, except per share data Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Net investment income per share $0.46 $0.46 $0.45 $0.42 $0.36 Net realized gains (losses) per share(1) ($0.08) ($0.14) $0.09 ($0.31) ($0.48) Net unrealized gains (losses) per share(1) $0.03 ($0.13) ($0.
Slide 8: Portfolio Highlights – Selected Metrics
Portfolio Highlights – Selected Metrics $ in millions, except per share data Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Investments at Fair Value $1,601 $1,581 $1,569 $1,563 $1,571 Number of Portfolio Companies 187 187 184 192 192 Median Portfolio Company EBITDA $29 $29 $29 $30 $31 Asset Mix of Investm
Slide 9: Quarterly Statements of Assets and Liabilities
Quarterly Statements of Assets and Liabilities As of ($ in thousands, except per share data) 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 Assets Investments, at fair value $1,600,692 $1,580,678 $1,569,418 $1,562,470 $1,570,668 Cash, cash equivalents and restricted cash 26,140 27,803 31,497 26,
Slide 10: Net Asset Value per Share Bridge
Net Asset Value per Share Bridge $0.36 $18.27 ($0.34) ($0.03) $0.03 $17.82 ($0.48) March 31, 2026 Net Regular Special Net Realized Net Change in June 30, 2026 NAV/Share Investment Dividend Dividend Losses on Exits Unrealized NAV/Share (1) (2) Income Distribution Distribution and Sales Appreciation (
Slide 11: Operating Results Detail
Operating Results Detail For the Three Months Ended ($ in thousands, except per share data) 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 Investment income Interest & dividend income $41,939 $40,938 $39,984 $37,532 $35,891 Other income 1,053 414 828 380 432 Total investment income $42,992 $41,3
Slide 12: Portfolio Highlights
Current or prospective client name Portfolio Highlights 12
Slide 13: Disciplined Portfolio Construction
Disciplined Portfolio Construction Designed to minimize losses via strong credit and non-credit risk mitigation $1,571mm First Lien (1) Investments at fair value(1) 98% 91% Floating Rate (1),(3) Wtd. Avg. Portfolio Company 192 Attachment Point & Leverage (2),(3),(4),(5) Portfolio 72% 98% companies N
Slide 14: Portfolio Diversity
Portfolio Diversity Diversification by Obligor Diversification by Industry(1) Top 10 Health Care Equipment & Services 16% Next 11-25 15% Software & Services 25% 18% Logan JV 2% Commercial & Professional Services ~$8mm 4% Remaining Consumer Services / 0.5% 6% 2% Average Insurance Position 9% Pharmace
Slide 15: Investment Activity
Investment Activity Conservative investment strategy with 91% of portfolio in first lien loans New Investment Fundings End of Period Investments At Cost. $ in millions At Fair Value. $ in millions $1,600.1 $1,570.7 $1,580.7 $1,569.4 $1,562.5 4% 5% 2% 2% 4% 2% 3% 5% 2% 5% 1% 1% 1% 1% 2% 2% 2% 1% 2% <
Slide 16: Portfolio Net Interest Margin
Portfolio Net Interest Margin(1) Weighted Average Yield of Income Producing Securities (at Cost) (2) Weighted Average Stated Interest Rate on Debt Outstanding Weighted Average Spread Over SOFR of Floating Rate Debt Investments 3 Month Term Secured Overnight Financing Rate ("SOFR") 14.0% 12.0% 10.4%
Slide 17: Investment Portfolio Performance Ratings
Investment Portfolio Performance Ratings Internal Performance Rating Migration % of Portfolio at Fair Value 86% 87% 86% 86% 85% 11% 10% 11% 10% 12% 3% 3% 3% 4% 3% Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Internal Performance Ratings 4 & 5 Internal Performance Rating 3 Internal Performance Ratings 1 &
Slide 18: Capital Structure
Current or prospective client name Capital Structure 18
Slide 19: Liquidity Management
Liquidity Management Short term flexibility of $200 million of undrawn debt capacity Debt Summary Debt Maturities ($ in millions) ($ in millions) Total Principal Interest Maturity $199 Committed Amount Rate Date Amount Outstanding SPV Asset Facility $500 $378 S+200 5/31/29 SMBC Corporate 335 258 S+2